- Home
- EBON vs BNR Comparison
EBON vs BNR Comparison
Compare EBON & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- BNR
- Stock Information
- Founded
- EBON 2010
- BNR 2014
- Country
- EBON China
- BNR China
- Employees
- EBON N/A
- BNR N/A
- Industry
- EBON Semiconductors
- BNR Medical Specialities
- Sector
- EBON Technology
- BNR Health Care
- Exchange
- EBON Nasdaq
- BNR Nasdaq
- Market Cap
- EBON 25.3M
- BNR 29.1M
- IPO Year
- EBON 2020
- BNR 2020
- Fundamental
- Price
- EBON $5.11
- BNR $4.22
- Analyst Decision
- EBON
- BNR
- Analyst Count
- EBON 0
- BNR 0
- Target Price
- EBON N/A
- BNR N/A
- AVG Volume (30 Days)
- EBON 30.1K
- BNR 29.7K
- Earning Date
- EBON 08-22-2025
- BNR 08-21-2025
- Dividend Yield
- EBON N/A
- BNR N/A
- EPS Growth
- EBON N/A
- BNR N/A
- EPS
- EBON N/A
- BNR N/A
- Revenue
- EBON $5,868,771.00
- BNR $72,112,038.00
- Revenue This Year
- EBON N/A
- BNR $136.32
- Revenue Next Year
- EBON N/A
- BNR N/A
- P/E Ratio
- EBON N/A
- BNR N/A
- Revenue Growth
- EBON 20.88
- BNR 0.53
- 52 Week Low
- EBON $3.00
- BNR $2.18
- 52 Week High
- EBON $10.94
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- EBON 75.89
- BNR 63.77
- Support Level
- EBON $3.28
- BNR $3.06
- Resistance Level
- EBON $3.49
- BNR $3.50
- Average True Range (ATR)
- EBON 0.31
- BNR 0.21
- MACD
- EBON 0.09
- BNR 0.05
- Stochastic Oscillator
- EBON 95.54
- BNR 95.65
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.